← Back to Clinical Trials
Recruiting NCT07018336

Mirror vs Virtual Reality Therapy for Upper Extremity Function in Hemiplegic Patients

Trial Parameters

Condition Hemiplegia
Sponsor Istinye University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 42
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2025-05-30
Completion 2026-07
Interventions
Mirror TherapyVirtual Reality (VR) Therapy

Brief Summary

Upper extremity impairment in hemiplegic patients significantly impacts daily activities and reduces quality of life. Although traditional rehabilitation methods can help, some patients experience limited progress. Recently, modern techniques such as mirror therapy and virtual reality (VR) have emerged, demonstrating promising results in motor skill improvement. This study aims to directly compare the acute effects of mirror therapy and VR therapy on upper limb motor function in hemiplegic patients. Forty-two participants aged 18-75 with hemiplegia due to stroke (6-12 months post-stroke) will be randomly assigned to either mirror therapy or VR therapy. The evaluation includes motor function (Fugl-Meyer Assessment), spasticity (Modified Ashworth Scale), activities of daily living (Barthel Index), fine motor skills (Box and Block Test), proprioception, and reaction time. The goal is to identify the effectiveness of the mirror therapy and VR therapy on motor function, spasticity control, proprioception, daily activity performance, and reaction times, contributing valuable insights to clinical rehabilitation practices.

Eligibility Criteria

Inclusion Criteria: * Hemiplegic patients in need of upper extremity rehabilitation. * Having had a stroke 6 to 12 months prior to the study. * Being at least Stage 3 for the upper extremity according to the Brunnstrom motor recovery stages. * Age range: between 18 and 75 years. * Individuals who volunteer to participate in the study. * Individuals who are cognitively suitable for mirror therapy and virtual reality applications (a score of at least 24 on the Mini Mental State Examination) Exclusion Criteria: * Patients with severe spasticity (score ≥ 3 on the Modified Ashworth Scale) * Individuals with secondary neurological conditions (e.g., Parkinson's disease, multiple sclerosis). * Individuals diagnosed with vestibular dysfunction (as virtual reality equipment may cause issues like nausea or dizziness). * Individuals with communication issues, such as hearing or vision loss.

Related Trials